COMMUNIQUÉS West-GlobeNewswire

Ultimovacs Announces Topline Data from FOCUS Phase II Trial of UV1 Combined with Pembrolizumab in Patients with Metastatic or Recurrent Head and Neck Cancer
05/08/2024
Adding Ultimovacs’ cancer vaccine UV1 to checkpoint inhibitor pembrolizumab did not meet primary or secondary endpoints in patients with metastatic or recurrent head and neck squamous cell carcinoma UV1 continues to [...]
Osteal Therapeutics Presents Positive Six-Month Results from the APEX Clinical Trial Program at the 34th Annual Musculoskeletal Infection Society Meeting
05/08/2024
The six-month efficacy endpoint of overall success showed a statistically significant improvement over standard of care, two-stage exchange arthroplasty DALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Osteal Therapeutics, Inc [...]
Transparency Notification from Shareholders
05/08/2024
PRESS RELEASE REGULATED INFORMATION 5 August 2024, 06 pm CEST Transparency Notification from Shareholders Ghent, Belgium – 5 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana [...]
Ipsen - July 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
05/08/2024
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Juillet 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
05/08/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
RAMSAY SANTE : Non audited consolidated financial statements for FY24
05/08/2024
PRESS RELEASE Paris, 5 August 2024 Ramsay Health Care publishes certain financial information about its non audited consolidated financial statements for FY24 Ramsay Santé relays the press release (attached) issued [...]
RAMSAY SANTE : Eléments financiers consolidés non audités à fin juin 2024
05/08/2024
COMMUNIQUÉ DE PRESSE Paris, le 5 août 2024 Ramsay Health Care publie certains éléments financiers consolidés non audités à fin juin 2024 Ramsay Santé relaie le communiqué de presse (ci-joint) publié ce jour par Ramsay [...]
Report: At $686,000 Orthopedic Surgeons Earn The Highest Physician Starting Salary
05/08/2024
Pediatricians Are at the Low End at $244,000 DALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Orthopedic surgeons are offered the highest average starting salary among physicians at $686,000, while pediatricians are at the low [...]
Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients
05/08/2024
New lab currently provides Whole Transcriptomic RNA Sequencing for the Undiagnosed Diseases Network’s nationwide clinical institutions HOUSTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics , a joint venture [...]
OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024
05/08/2024
PRESS RELEASE OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024 Oxford, United Kingdom – 5 th August 2024 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying [...]
Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
05/08/2024
AUSTIN, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today reflected on the passing of long-time board member Sanford Robertson. We are profoundly saddened by the passing of our dear [...]
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE
05/08/2024
Market research data shows interest in additional glucose monitoring options for people with diabetes who use insulin Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or [...]
NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility
05/08/2024
Proceeds to be used for OneRF commercialization activities and to bridge the Company to the close of a potential distribution arrangement with a strategic partner currently in the diligence process EDEN PRAIRIE, Minn., [...]
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
05/08/2024
CARMEL, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Dror Ortho-Design, Inc. Launches ZSMILE User Experience Trial
05/08/2024
JERUSALEM, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's [...]
AFB Names 2024 Migel Medal Honorees
05/08/2024
WASHINGTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) has announced that Kim Charlson and Susan Mazrui are the winners of the Migel Medal, the highest honor in the field of blindness [...]
Merus annonce ses résultats financiers pour le deuxième trimestre 2024 et fait le point sur ses activités
03/08/2024
- Données provisoires de l’association pétosemtamab + pembrolizumab présentées lors de l’édition 2024 du congrès de l’ASCO ® , avec démonstration d’un taux de réponse solide de 67 % chez 24 patients évaluables. – [...]
NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH
02/08/2024
Company announcement no. 6 – 24 2 August 2024 NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH NTG Germany GmbH (“NTG”), a fully owned subsidiary of NTG Nordic Transport Group A/S, has signed an agreement [...]
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
02/08/2024
PDUFA Action Date for the Arimoclomol NDA is September 21, 2024 CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company [...]

Pages